Structural characteristics of osteopontin for calcium oxalate crystal

Japanese Journal of Urology

Volumn 90, Issue 3, 1999, Pages 436-444

  Umekawa, Tohru ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Osteopontin; Seed crystal method; Undiluted urine method

Indexed keywords

CALCIUM OXALATE; OSTEOPONTIN; SIALIC ACID;

ANALYTIC METHOD; ARTICLE; CRYSTAL STRUCTURE; DILUTION; ENZYME PURIFICATION; GROWTH INHIBITION; HUMAN; SCANNING ELECTRON MICROSCOPY; STONE FORMATION; UROLITHIASIS;

EID: 0032952241     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.90.436     Document Type: Article

References (33)

1. Nakagawa, Y., Abram, V., Kedzy, F.J., Kiser, E.T. and Coe, F L. : Purification and Characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J. Bio. Chem., 258, 12594-12600, 1983.
2. Kohri, K., Suzuki, Y., Yoshida, K., Yamamoto, K., Amasaki, N., Yamate, T., Umekawa, T., Iguchi, M., Sinohara, H. and Kurita, T. : Molecular cloning and sequencing of cDNA encoding urinary stone protein. which is identical to osteopontin. Biochem. Biophys. Res. Commun., 184, 859-864, 1992.
3. Umekawa, T. and Kurita, T. : Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone. Biochem. Mol. Bio. Int., 34, 309-313, 1994.
4. Umekawa, T., Kohri, K., Amasaki, N., Yamate, T., Yoshida, K., Yamamoto, K., Suzuki, Y., Sinohara, H. and Kurita, T. : Sequence of urinary protein. identical to alpha-one antitrypsin. which lacks 22 amino acids. Biochem. Biophys. Res. Commun., 193, 1049-1053, 1993.
5. Atmani, F., Lacour, B., Jungers, P., Drucke, T. and Daudon , M . : Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers. Urol. Res., 22, 257-260, 1994.
6. Suzuki, K., Moriyama, M., Nakajima, C., Kawamura, K., Miyazawa, K., Tsugawa, R., Kikuchi, N. and Nagata,. K. : Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation : evidence of activation peptide of human prothrombin. Urol. Res , 22, 45-50, 1994.
7. Honda, M., Yoshioka, T., Yamaguchi, S., Yoshimura, K., Miyake, O., Utsunomiya, M., Koide, T. and Okuyama. A. : Characterization of protein components of human urinary crystal surface binding substance. Urol. Res., 22, 355-360, 1997.
8. Tang, Y., Grover, P.K., Moritz, R.L., Simpson, R.J. and RyalL R.L. : Is nephrocalcin related to the urinary derivative (bikunin) of inter-α-trypsin inhibitor? Br. J. Urol., 76, 425-430, 1995.
9. Yamate, T., Umekawa, T., Iguchi, M. and Kurita, T. : Detection of osteopontin as matrix protein in calcium-containing urinary stones. Acta Urol. Jpn., 43, 623-627, 1997.
10. Oldberg, A., Franzen, A. and Heingard, D. : Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cellbinding sequence. Proc. Natl. Acad. Sci. USA. 83, 8819-8823, 1986.
11. Hirota, S., Imakita, M., Kohri, K., Ito, A., Moruii, E., Adachi, S., Kim, H., Kitamura, Y., Yutani, C., and Nomura, S. : Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A. J. PathoL 143, 1003-1008, 1993.
12. Chambers, A.F., Hota, C. and Prince, C.W. : Adhesion of metastatic. ras-transformed NIH 3 T 3 cells to osteopondn. fibronectin. and laminin. Cancer Research, 53, 701-706, 1993.
13. Robertson, W.G. and Peacock, M. : Calcium oxalate crystalluria amd inhibitors of crystallization in recurrent renal stone-formers. Clinical Science, 43, 499-506, 1972.
14. Ryall, R.L., Hibberd, C.M. and Marshall, V.R : A method for studying inhibitory activity in whole urine. Urol. Res., 13, 285-289, 1985.
15. Senger, D.R., Perruzzi, C.A., Paradopoulos, A. and Tenen, D.G. : Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochem. Bio. Acta., 996, 43-48, 1989.
16. Kurita, T. and Umekawa, T. : Urinary stone - matrix ; osteopontin and calprotectin - . Acta Med. Kinki Univ., 20, 267-278,1995.
17. Kohri, K., Fujita, K., Itoh, T., Tawad, T., Sakakura, T., Umekawa, T. and Kurita, T. : Purification and characterization of urinary stone protein. Aktuelle Urologie. 27, 27-29, 1996.
18. Umekawa, T., Kohri, K . Kurita, T . Hirota, S., Nomura, S. and Kitamura, Y. : Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone. Biochem. Mol. Bio. Int., 35, 223-230, 1995.
19. Umekawa, T. Yamate, T., Amasaki, N., Kohri, K. and Kurita, T. : Osteoponun mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol. Int., 55, 6-10, 1995.
20. Amasaki, N., Yamate, T., Umekawa, T., Ishikawa, Y., Kajikawa, H. and Kurita, T. : Regulation of the expression of OPN mRNA in the rat as an expertmental model of renal stone disease, Int. Urol., 3, 88-91, 1996.
21. Kohri, K., Nomura, S., Kitamura, Y., Nagata, T., Yoshioka, K., Iguchi, M., Yamate, T., Umekawa, T., Suzuki, Y., Sinohara, H and Kurita, T. : Structure and expression of the mRNA encoding urinary stone protein (osteopontin) , J.Bio. Chem . 268, 15180-15184, 1993.
22. Yamate, T., Kohri, K., Umekawa, T., Amasaki. N., Ishikawa, Y., Iguchi, M. and Kurita, T. : The effect osteopontin on the adhesion of calcium oxalate crystals to madin-darby canine kidney cells, Eur. Urol., 30, 388-393, 1996.
23. Doi, Y., Okuda, R., Takezawa, Y., Shibata, S., Moriwaki, Y., Wakamatsu, N., Shimizu, N., Moriyama, K. and Shimokawa, H. : Osteopontin. inhibiting de novo formation of apatite in the presence of collagen. Calcif. Tissue Int., 44, 200-208, 1989.
24. Fujisawa, R., Kuboki, Y. and Sasaki, S. : Effects of dentin phosphophoryn on precipitation of calcium phosphate in gel in vitro, Calcif. Tissue Int., 41, 44-47, 1987.
25. Boskey, A.L., Maresca, M., Ullrich, W., Doty, S.B., Butler, W.T. and Prince, C.W. : Osteopontin-hydroxyapatite interactions in vitro : inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Mineral, 22, 147-159, 1993.
26. Craig, A.M. and Denhardt, D.T. : The Murine gene encoding secreted phosphoprotein 1 (osteopontin) : promoter structure. activity. and induction in vivo by estrogen and progesterone. Gene, 100, 163-171, 1991.
27. Manuel, M.P., Prince, C.W., Gay. S., Austin, R.L. and Butler, W.T. : 44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rais : kidney and nervous tissues. Cell Tissue Res , 251, 23-30, 1988.
28. Singh, K., Devouge, M.W. and Mukherjee, B.B. : Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J. Bio. Chem., 265, 18696-18701. 1990
29. Bautista, D.S., Denstedt, J , Chambers, A.F. and Harris, J.F. : High frequency of electrophoretic mobility variations of osteopontin in the urine of patients with calcium oxalate kidney stones. J. Urol., 153, 491, 1995.